{"entity":{"type":"insider","cik":"0001422997","url":"/insider/0001422997","json_url":"/insider/0001422997.json","name":"Bekker Petrus","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":74,"n_filings":25,"first":"2012-09-19","last":"2017-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Bekker Petrus","source":"filing","n_filings":25,"first_seen":"2012-09-19","last_seen":"2017-07-13"}],"transactions":[{"id":4784263,"accession":"0001209191-17-045120","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-17-045120","line_url":"/filing/0001209191-17-045120","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16013.0,"shares_display":"16,013","price_per_share":10.208217698120277,"price_display":"10.21","price_state":"stated","total_value":163464.19,"total_display":"163,464.19","total_whole":"163,464","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-13","filed_date":"2017-07-13","scope":"insider","n_lines":2},{"id":4784252,"accession":"0001209191-17-045120","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-17-045120","line_url":"/filing/0001209191-17-045120","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.976003886666666,"price_display":"9.98","price_state":"stated","total_value":299280.1166,"total_display":"299,280.12","total_whole":"299,280","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-12","filed_date":"2017-07-13","scope":"insider","n_lines":5},{"id":4784220,"accession":"0001209191-17-045120","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-045120","line_url":"/filing/0001209191-17-045120","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.77752,"price_display":"9.78","price_state":"stated","total_value":293325.6,"total_display":"293,325.60","total_whole":"293,326","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-11","filed_date":"2017-07-13","scope":"insider","n_lines":2},{"id":4564606,"accession":"0001209191-17-044704","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-044704","line_url":"/filing/0001209191-17-044704#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290.0,"shares_display":"290","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":2697.0,"total_display":"2,697.00","total_whole":"2,697","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-10","filed_date":"2017-07-10","scope":"insider"},{"id":4564597,"accession":"0001209191-17-044704","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-044704","line_url":"/filing/0001209191-17-044704#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19587.0,"shares_display":"19,587","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":182159.1,"total_display":"182,159.10","total_whole":"182,159","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-07","filed_date":"2017-07-10","scope":"insider"},{"id":5352134,"accession":"0001209191-17-042617","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-042617","line_url":"/filing/0001209191-17-042617","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.22901328,"price_display":"9.23","price_state":"stated","total_value":276870.3984,"total_display":"276,870.40","total_whole":"276,870","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-30","filed_date":"2017-06-30","scope":"insider","n_lines":2},{"id":5352123,"accession":"0001209191-17-042617","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-042617","line_url":"/filing/0001209191-17-042617#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5509.0,"shares_display":"5,509","price_per_share":9.1064,"price_display":"9.11","price_state":"stated","total_value":50167.1576,"total_display":"50,167.16","total_whole":"50,167","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-29","filed_date":"2017-06-30","scope":"insider"},{"id":5352117,"accession":"0001209191-17-042617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-042617","line_url":"/filing/0001209191-17-042617#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.1223,"price_display":"9.12","price_state":"stated","total_value":273669.0,"total_display":"273,669.00","total_whole":"273,669","shares_owned_after":59839.0,"shares_owned_after_display":"59,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-28","filed_date":"2017-06-30","scope":"insider"},{"id":3140235,"accession":"0001209191-16-156151","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-156151","line_url":"/filing/0001209191-16-156151","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8712.0,"shares_display":"8,712","price_per_share":8.737356519742884,"price_display":"8.74","price_state":"stated","total_value":76119.85,"total_display":"76,119.85","total_whole":"76,120","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider","n_lines":2},{"id":2141795,"accession":"0001209191-16-154015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-154015","line_url":"/filing/0001209191-16-154015#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":255000.0,"total_display":"255,000.00","total_whole":"255,000","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-05","filed_date":"2016-12-07","scope":"insider"},{"id":3046362,"accession":"0001209191-16-151999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-151999","line_url":"/filing/0001209191-16-151999#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":8.3,"price_display":"8.30","price_state":"stated","total_value":10375.0,"total_display":"10,375.00","total_whole":"10,375","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-22","filed_date":"2016-11-23","scope":"insider"},{"id":3046223,"accession":"0001209191-16-149759","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-149759","line_url":"/filing/0001209191-16-149759#line-6","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2698.0,"shares_display":"2,698","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":21584.0,"total_display":"21,584.00","total_whole":"21,584","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-14","scope":"insider"},{"id":3046217,"accession":"0001209191-16-149759","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-149759","line_url":"/filing/0001209191-16-149759#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":240000.0,"total_display":"240,000.00","total_whole":"240,000","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-10","filed_date":"2016-11-14","scope":"insider"},{"id":3046211,"accession":"0001209191-16-149759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-149759","line_url":"/filing/0001209191-16-149759#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":634.0,"shares_display":"634","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":5072.0,"total_display":"5,072.00","total_whole":"5,072","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":4305441,"accession":"0001209191-13-040154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-040154","line_url":"/filing/0001209191-13-040154#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.2566,"price_display":"13.26","price_state":"stated","total_value":66283.0,"total_display":"66,283.00","total_whole":"66,283","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-07","filed_date":"2013-08-09","scope":"insider"},{"id":5539123,"accession":"0001209191-13-037326","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-13-037326","line_url":"/filing/0001209191-13-037326","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.5394,"price_display":"14.54","price_state":"stated","total_value":145394.0,"total_display":"145,394.00","total_whole":"145,394","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-17","filed_date":"2013-07-19","scope":"insider","n_lines":2},{"id":4755864,"accession":"0001209191-13-033995","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-033995","line_url":"/filing/0001209191-13-033995#line-6","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3016.0,"shares_display":"3,016","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":42224.0,"total_display":"42,224.00","total_whole":"42,224","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-27","filed_date":"2013-06-27","scope":"insider"},{"id":4755857,"accession":"0001209191-13-033995","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-033995","line_url":"/filing/0001209191-13-033995#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117.0,"shares_display":"117","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1638.0,"total_display":"1,638.00","total_whole":"1,638","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-26","filed_date":"2013-06-27","scope":"insider"},{"id":4755850,"accession":"0001209191-13-033995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-033995","line_url":"/filing/0001209191-13-033995#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1867.0,"shares_display":"1,867","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":26138.0,"total_display":"26,138.00","total_whole":"26,138","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-25","filed_date":"2013-06-27","scope":"insider"},{"id":5305773,"accession":"0001209191-13-033049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-033049","line_url":"/filing/0001209191-13-033049#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.0002,"price_display":"12.00","price_state":"stated","total_value":60001.0,"total_display":"60,001.00","total_whole":"60,001","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-19","scope":"insider"},{"id":5398977,"accession":"0001209191-13-029159","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-029159","line_url":"/filing/0001209191-13-029159#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82.0,"shares_display":"82","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1148.0,"total_display":"1,148.00","total_whole":"1,148","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-24","filed_date":"2013-05-28","scope":"insider"},{"id":5398973,"accession":"0001209191-13-029159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-029159","line_url":"/filing/0001209191-13-029159#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4718.0,"shares_display":"4,718","price_per_share":14.0004,"price_display":"14.00","price_state":"stated","total_value":66053.8872,"total_display":"66,053.89","total_whole":"66,054","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-23","filed_date":"2013-05-28","scope":"insider"},{"id":4643569,"accession":"0001209191-13-028211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-028211","line_url":"/filing/0001209191-13-028211#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2800.0,"total_display":"2,800.00","total_whole":"2,800","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-20","filed_date":"2013-05-22","scope":"insider"},{"id":5300474,"accession":"0001209191-13-027419","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-027419","line_url":"/filing/0001209191-13-027419#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.5946,"price_display":"13.59","price_state":"stated","total_value":67973.0,"total_display":"67,973.00","total_whole":"67,973","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-17","filed_date":"2013-05-17","scope":"insider"},{"id":5300467,"accession":"0001209191-13-027419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-027419","line_url":"/filing/0001209191-13-027419#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.1598,"price_display":"14.16","price_state":"stated","total_value":141598.0,"total_display":"141,598.00","total_whole":"141,598","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider"},{"id":5559641,"accession":"0001209191-13-021323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-021323","line_url":"/filing/0001209191-13-021323#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3979.0,"shares_display":"3,979","price_per_share":14.0309,"price_display":"14.03","price_state":"stated","total_value":55828.9511,"total_display":"55,828.95","total_whole":"55,829","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-11","filed_date":"2013-04-12","scope":"insider"},{"id":5038080,"accession":"0001209191-13-019878","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-019878","line_url":"/filing/0001209191-13-019878#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64.0,"shares_display":"64","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":896.0,"total_display":"896.00","total_whole":"896","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-02","scope":"insider"},{"id":5038070,"accession":"0001209191-13-019878","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-019878","line_url":"/filing/0001209191-13-019878#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":957.0,"shares_display":"957","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":13398.0,"total_display":"13,398.00","total_whole":"13,398","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-01","filed_date":"2013-04-02","scope":"insider"},{"id":5366274,"accession":"0001209191-13-017586","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-13-017586","line_url":"/filing/0001209191-13-017586#line-15","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.6111,"price_display":"13.61","price_state":"stated","total_value":68055.5,"total_display":"68,055.50","total_whole":"68,056","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider"},{"id":5366261,"accession":"0001209191-13-017586","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-13-017586","line_url":"/filing/0001209191-13-017586","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8889.0,"shares_display":"8,889","price_per_share":14.057033175835302,"price_display":"14.06","price_state":"stated","total_value":124952.9679,"total_display":"124,952.97","total_whole":"124,953","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider","n_lines":6},{"id":5299377,"accession":"0001209191-13-016685","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-13-016685","line_url":"/filing/0001209191-13-016685#line-6","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":12600.0,"total_display":"12,600.00","total_whole":"12,600","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-14","scope":"insider"},{"id":5299373,"accession":"0001209191-13-016685","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-016685","line_url":"/filing/0001209191-13-016685#line-4","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3212.0,"shares_display":"3,212","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":44968.0,"total_display":"44,968.00","total_whole":"44,968","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-14","scope":"insider"},{"id":5299368,"accession":"0001209191-13-016685","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-016685","line_url":"/filing/0001209191-13-016685#line-2","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4276.0,"shares_display":"4,276","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":59864.0,"total_display":"59,864.00","total_whole":"59,864","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-14","scope":"insider"},{"id":4561241,"accession":"0001209191-13-015691","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-13-015691","line_url":"/filing/0001209191-13-015691#line-16","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600.0,"shares_display":"2,600","price_per_share":14.0019,"price_display":"14.00","price_state":"stated","total_value":36404.94,"total_display":"36,404.94","total_whole":"36,405","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-11","scope":"insider"},{"id":4561235,"accession":"0001209191-13-015691","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-13-015691","line_url":"/filing/0001209191-13-015691#line-15","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":14.0127,"price_display":"14.01","price_state":"stated","total_value":15413.97,"total_display":"15,413.97","total_whole":"15,414","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-11","scope":"insider"},{"id":4561230,"accession":"0001209191-13-015691","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-13-015691","line_url":"/filing/0001209191-13-015691#line-14","is_derivative":false,"issuer_cik":"0001340652","issuer_name":"ChemoCentryx, Inc.","issuer_ticker":"CCXI","issuer_name_source":null,"issuer_url":"/issuer/0001340652","owner_cik":"0001422997","owner_name":"Bekker Petrus","owner_display_name":"Bekker Petrus","owner_url":"/insider/0001422997","role":"Officer (SVP of Medical & Clinical)","role_mark":"O","role_mark_label":"Officer (SVP of Medical & Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP of Medical & Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":14.0045,"price_display":"14.00","price_state":"stated","total_value":15404.95,"total_display":"15,404.95","total_whole":"15,405","shares_owned_after":53594.0,"shares_owned_after_display":"53,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-11","scope":"insider"}],"collapsed":true,"next_cursor":"2013-03-11|4561230","ledger_fault":false,"count":{"value":74,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":74,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":74},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001340652","name":"ChemoCentryx, Inc.","url":"/issuer/0001340652","role":"Officer (Chief Medical Officer)","n_filings":25,"first_seen":"2012-09-19","last_seen":"2017-07-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001422997","retrieved_at":"2026-08-22T23:06:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}